San Diego-based GenWay Biotech, Inc. today announced the availability of the You Test You Cancer Assessment that allows patients to test for various types of cancer without having to visit their doctor's office, through a simple blood sample. With a 10-day turnaround time and a cost of $149, You Test You is a convenient and low cost way to periodically test for indication of cancer.
The test can be ordered online through the www.youtestyou.com Web site. The patient completes an online form, which is reviewed by a You Test You doctor. Upon approval, the patient visits a local laboratory to have a blood sample taken. You Test You is an easily accessible and effective method for detecting evidence of cancer, which may lead to diagnosing and treating cancer earlier. Diagnosing cancer in the early stages can lead to successful treatment and an increased survival rate.
"The American Cancer Society has stressed the importance of early cancer detection, yet for various reasons, many Americans do not have regular checkups with their doctors", said GenWay CEO Robert Gans. "This convenient and inexpensive test will provide a valuable means for patients to be proactive and evaluate certain proteins found in the blood which are frequently associated with most cancers"
George Delgado, M.D., specialist in family medicine and voluntary associate clinical professor at UC San Diego says, "The You Test You Cancer Assessment is a great test for people who want to take charge of their health and make better health decisions."
The launch of You Test You is particularly timely, given recent recommendations from various sources setting guidelines for both breast and cervical cancer screening. The test is the first of its kind for cancer, helping patients monitor their own health. In addition to the lab-based test, a home sample collection kit will be available early this year.
According to Sergey Sikora, GenWay's Vice President of Business Development, "You Test You is a step toward putting health care into the hands of patients, many of whom do not have the time or money for expensive cancer testing. We are proud to offer a test that, with a prescription from our doctor, is widely accessible to the general consumer."
|Contact: Jill Dombrauckas|